antwerpes AG

euro adhoc: DocCheck AG
Financial Figures/Balance Sheet
Provisional 2005 figures for the DocCheck Group: • Turnover up 6 % to 11.2 million euro • proposition: 8 cent dividend • 10 % sales growth projected for 2006

-------------------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- 02.03.2006 DocCheck AG, Cologne, (ISIN DE0005471007 // WKN 547100) has ended its 2005 financial year on a good final quarter and increased its turnover and operating result over the year as a whole. According to provisional figures, sales improved during the last quarter of 2005, compared with the same quarter of the previous year for the group, by 18 % to 3.2 million euro; EBIT was up 6 % to 0.25 million euro. The year as a whole saw sales growth of 6 % from 10.5 million euro to 11.2 million euro. Earnings before interest and tax (EBIT) improved by 18 % over this period from 0.4 million euro to 0.5 million euro. Sales in the DocCheck, Commerce & Logistic division rose by 26 % over the previous year’s figure to 5.7 million euro, meaning that DocCheck, Commerce & Logistic generated over 50 % of group turnover for the first time. At 5.5 million euro, sales in the Communication division (antwerpes & partner ag) were still 8 % below the previous year’s level. This was due to a poor performance during the first six months of the year. During the second half of the year however there was an improvement of 11 % over last year’s figures, indicating that the agency business of the DocCheck group is also back on track for growth. Profit per share remains at the previous year’s level of 11 cents (previous year: 11 cents). At the Annual General Meeting to be held on 31 May 2006, the Board of Directors and Supervisory Board will propose a dividend of 8 cents again. The funding level (liquid funds and current-asset securities) has risen by 1.4 million euro from the level at the end of the third quarter of 2005, from 15.7 million euro to 17.1 million euro, to total 2.90 euro per share. DocCheck AG is aiming to improve sales by 10 %, to achieve a figure of 12.3 million euro during the current financial year. end of announcement euro adhoc 02.03.2006 20:00:00 -------------------------------------------------------------------------------- ots Originaltext: antwerpes AG Im Internet recherchierbar: http://www.presseportal.de Further inquiry note: Tanja Mumme +49 (0)221 92053 139 tanja.mumme@doccheck.com Branche: Computing & Information Technology ISIN: DE0005471007 WKN: 547100 Index: CDAX, Prime All Share, Technologie All Share Börsen: Frankfurter Wertpapierbörse / regulated dealing/prime standard Börse Berlin-Bremen / free trade Hamburger Wertpapierbörse / free trade Baden-Württembergische Wertpapierbörse / free trade Börse Düsseldorf / free trade Bayerische Börse / free trade

Das könnte Sie auch interessieren: